All Comments by
- Timothy Clark on Endowed Lectureship to Honor the Late Mark Smith
- Glyn Wainwright on Is Alzheimer's a Type 3 Diabetes?
- Glyn Wainwright on Cholesterol and Alzheimer's—Charging Fast But Still at a Distance from Solid Answers
- Michael Schlossmacher on Herpes Simplex and Alzheimer’s—Time to Think Again?
- Takaomi Saido on Combinatorial Tau pseudophosphorylation: markedly different regulatory effects on microtubule assembly and dynamic instability than the sum of the individual parts.
- Takaomi Saido on Two distinct amyloid beta-protein (Abeta) assembly pathways leading to oligomers and fibrils identified by combined fluorescence correlation spectroscopy, morphology, and toxicity analyses.
- Bhaskar Das on Design and synthesis of potential retinoid based PET imaging agents to study Alzheimer's disease biology.
- Chris Carter on Herpes Simplex and Alzheimer’s—Time to Think Again?
- M. Flint Beal on Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.
- Russell Swerdlow on Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.
- Barry Boland on Sphingolipid storage affects autophagic metabolism of the amyloid precursor protein and promotes Abeta generation.
- Glyn Wainwright on The Role of Insulin Resistance in Brain Aging and Dementia
- Robert Moir on Crystal structure of the amyloid-β p3 fragment provides a model for oligomer formation in Alzheimer's disease.
- Helen Cunningham on Miami: Is Human Amyloid Imaging Ready for Clinical Trials?
- Jose Joaquin Merino on Genetics of FTD: New Gene, PGRN Variety, and a Bit of FUS